AstraZeneca tops FTSE 100 after lung cancer treatment gets green light
Lung cancer treatment gets US approvalRisk of disease progression cut by 38%Lung cancer a leading cause of deathsShares in AstraZeneca (AZN) topped the FTSE 100 leaderboard on Monday after the pharmaceutical firm said its lung...
19 February 2024